| FRANKLIN DISRUPTIVE COMMERCE I (ACC) USD | RVI CONSUMO | -10,56% | 39,75% | · | · |
| FRANKLIN DISRUPTIVE COMMERCE N (ACC) EUR | RVI CONSUMO | -11,44% | 32,25% | · | · |
| FRANKLIN DISRUPTIVE COMMERCE N (ACC) USD | RVI CONSUMO | -12,06% | 32,84% | · | · |
| FRANKLIN DISRUPTIVE COMMERCE W (ACC) USD | RVI CONSUMO | -10,70% | 39,36% | · | · |
| FRANKLIN EMERGING MARKET CORPORATE DEBT P2 (ACC) USD | DEUDA PRIVADA EMERGENTES | 7,78% | · | · | · |
| FRANKLIN EUROPEAN TOTAL RETURN S (ACC) EUR | RFI EUROPA | -0,98% | · | · | · |
| FRANKLIN EUROPEAN TOTAL RETURN S (ACC) USD-H1 | RFI EUROPA | 4,36% | · | · | · |
| FRANKLIN EUROPEAN TOTAL RETURN S (MDIS) EUR | RFI EUROPA | -4,04% | · | · | · |
| FRANKLIN EUROPEAN TOTAL RETURN S (MDIS) USD-H1 | RFI EUROPA | 1,21% | · | · | · |
| FRANKLIN EURO SHORT DURATION BOND EB (QDIS) EUR | RF EURO CORTO PLAZO | -2,25% | 0,50% | · | · |
| FRANKLIN EURO SHORT DURATION BOND S (ACC) EUR | RF EURO CORTO PLAZO | 0,46% | 9,42% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 26,92% | 38,30% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) USD | RVI BIOTECNOLOGÍA | 34,33% | 39,29% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (YDIS) EUR | RVI BIOTECNOLOGÍA | 35,19% | 38,59% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS C (ACC) USD | RVI BIOTECNOLOGÍA | 33,49% | 37,03% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) EUR | RVI BIOTECNOLOGÍA | 36,49% | 42,57% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) USD | RVI BIOTECNOLOGÍA | 35,61% | 43,50% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) EUR | RVI BIOTECNOLOGÍA | 34,06% | 35,67% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) USD | RVI BIOTECNOLOGÍA | 33,30% | 36,39% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS W (ACC) USD | RVI BIOTECNOLOGÍA | 35,33% | 43,24% | · | · |
